Risk Factors of FEV<sub>1</sub>/FVC Decline in COPD Patients
We identified the risk factors for rapid FEV₁/FVC decline, including BMI, smoking, symptoms deterioration, FEV₁ decline, and adherence to standard inhaler treatment. Our findings underscore the potential benefits of maintaining consistent use of long-acting beta-agonist/long-acting muscarinic antagonist even in the presence of worsening symptoms, in attenuating FEV₁/FVC decline.
Authors
- Jin Hwa Lee (ORCID: https://orcid.org/0000-0003-0843-9862)
- Deog Kyeom Kim (ORCID: https://orcid.org/0000-0001-9379-8098)
- Shinhee Park (ORCID: https://orcid.org/0000-0002-5783-6795)
- Kwang Ha Yoo (ORCID: https://orcid.org/0000-0001-9969-2657)
- Hyewon Seo (ORCID: https://orcid.org/0000-0003-0533-8863)
- Seoung Ju Park (ORCID: https://orcid.org/0000-0003-0454-6118)
- Na Young Kim (ORCID: https://orcid.org/0000-0002-4123-8619)
- Dongil Park (ORCID: https://orcid.org/0000-0001-7329-1724)
- Hyun Woo Lee (ORCID: https://orcid.org/0000-0003-4379-0260)
- Young‐il Hwang (ORCID: https://orcid.org/0000-0002-5777-7983)
Institutions
- Ewha Womans University (KR)
- Seoul National University (KR)
- Chungnam National University (KR)
- Konkuk University (KR)
- Soonchunhyang University (KR)
- Seoul Metropolitan Government (KR)
- Kyungpook National University (KR)
- SNUH SMG-SNU Boramae Medical Center (KR)
- Hallym University Dongtan Sacred Heart Hospital (KR)
- Hallym University Sacred Heart Hospital (KR)
- Bucheon University (KR)
- Jeonbuk National University (KR)
Publication Details
- Journal
- Journal of Korean Medical Science
- Published
- 2024-11-21
- DOI
- https://doi.org/10.3346/jkms.2025.40.e32
- Citations
- 4
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 1.68
Funders
- Korea National Institute of Health